Multi-peptide Vaccination

Multi-peptide Vaccination Uses, Dosage, Side Effects, Food Interaction and all others data.

Sponsored by the University Hospital Tuebingen in Germany, Multi-peptide Vaccination is a multi-peptide COVID-19 vaccine candidate created from HLA class I and HLA-DR T-cell epitopes of the S-protein. It is being investigated in the clinical trial NCT04546841 (Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults (pVAC)) and aims to induce broad T-cell immunity.

Trade Name Multi-peptide Vaccination
Generic CoVac-1
CoVac-1 Other Names Multi-peptide vaccination, Multipeptide cocktail
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Multi-peptide Vaccination
Multi-peptide Vaccination

Innovators Monograph

You find simplified version here Multi-peptide Vaccination


*** Taking medicines without doctor's advice can cause long-term problems.
Share